Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

ModernaTX, Inc. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
messenger-rnarespiratory-syncytial-virussafetysars-cov-2vaccines
respiratory syncytial virus, viral diseases, messenger rna, moderna, mrna-1345, safety, vaccines, sars-cov-2, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 857668
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.